Meridiem Capital Partners’s Medtronic MDT Stock Holding History

Meridiem Capital Partners’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-208,685	Closed	-$20M	–	84
2025 Q4	$20M	Sell	208,685 -117,066	-36%	-$11.4M	1.21%	35
2025 Q3	$31M	Buy	325,751 +147,275	+83%	+$13.5M	1.98%	17
2025 Q2	$15.6M	Buy	+178,476	New	+$15.1M	1.1%	38
2025 Q1	–	Sell	-157,481	Closed	-$12.6M	–	88
2024 Q4	$12.6M	Buy	+157,481	New	+$13.6M	1.11%	34

Other funds holding MDT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Meridiem Capital Partners's MDT Position: Q1 2026 in Review

Meridiem Capital Partners sold out of Medtronic (MDT) in Q1 2026, closing a stake of 208,685 shares — an estimated $20M sold.

Meridiem Capital Partners first reported a position in MDT in Q4 2024 and held it in 4 quarters. The position peaked at $31M in Q3 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

Meridiem Capital Partners reported no remaining Medtronic position as of Q1 2026 after selling out during the quarter.
Meridiem Capital Partners sold 208,685 Medtronic shares in Q1 2026, an estimated $20M.
Meridiem Capital Partners first reported a position in Medtronic in Q4 2024 and held it in 4 quarters.
Meridiem Capital Partners's Medtronic position peaked at $31M in Q3 2025.
2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Meridiem Capital Partners's 13F filing for Q1 2026, filed 15 May 2026.